Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Grove IncCommon Stock (GRVI) stocks in Canada

Learn how to easily invest in Grove IncCommon Stock stocks.

Grove IncCommon Stock is a drug manufacturers-specialty & generic business based in the US. Grove IncCommon Stock stocks (GRVI.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.18 – a decrease of 2.59% over the previous week. Grove IncCommon Stock employs 122 staff and has a trailing 12-month revenue of around $29.6 million.

How to buy shares in Grove IncCommon Stock

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GRVI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Grove IncCommon Stock stock price (NASDAQ:GRVI)

Use our graph to track the performance of GRVI stocks over time.

Grove IncCommon Stock shares at a glance

Information last updated 2022-01-26.
Latest market close$4.13
52-week range$3.84 - $9.37
50-day moving average $4.48
200-day moving average $5.10
Wall St. target price$10.00
PE ratio 15.9559
Dividend yield N/A (0%)
Earnings per share (TTM) $0.27

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Grove IncCommon Stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Grove IncCommon Stock price performance over time

Historical closes compared with the close of $4.13 from 2022-01-26

1 week (2022-01-21) -2.59%
1 month (2021-12-28) 0.49%
3 months (2021-10-28) -27.29%
6 months (2021-07-28) -26.51%
1 year (2021-01-24) N/A
2 years (2020-01-24) N/A
3 years (2019-01-24) N/A
5 years (2017-01-24) N/A

Is Grove IncCommon Stock under- or over-valued?

Valuing Grove IncCommon Stock stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Grove IncCommon Stock's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Grove IncCommon Stock's P/E ratio

Grove IncCommon Stock's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Grove IncCommon Stock shares trade at around 16x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Grove IncCommon Stock's P/E ratio is best considered in relation to those of others within the drug manufacturers-specialty & generic industry or those of similar companies.

Grove IncCommon Stock's EBITDA

Grove IncCommon Stock's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.7 million.

The EBITDA is a measure of a Grove IncCommon Stock's overall financial performance and is widely used to measure a its profitability.

To put Grove IncCommon Stock's EBITDA into context you can compare it against that of similar companies.

Grove IncCommon Stock financials

Revenue TTM $29.6 million
Operating margin TTM 8.86%
Gross profit TTM $11.9 million
Return on assets TTM 8.41%
Return on equity TTM 32.2%
Profit margin 14.52%
Book value $1.58
Market capitalisation $71.1 million

TTM: trailing 12 months

Grove IncCommon Stock share dividends

We're not expecting Grove IncCommon Stock to pay a dividend over the next 12 months.

Grove IncCommon Stock overview

Grove, Inc. , through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol. The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors. It also operates annual tradeshow related to the CBD industry in the United States. The company was incorporated in 2018 and is headquartered in Henderson, Nevada. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site